Sublingual Allergy Immunotherapy Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025-2032

Description

Persistence Market Research has recently released a comprehensive report on the worldwide market for sublingual allergy immunotherapy. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure. This research publication presents exclusive data and statistics outlining the anticipated growth trajectory of the global sublingual allergy immunotherapy market from 2025 to 2032.

Key Insights:

Sublingual Allergy Immunotherapy Market Size (2025E): US$ 1,092.20 Million

Projected Market Value (2032F): US$ 2,022.40 Million

Global Market Growth Rate (CAGR 2025 to 2032):9.2%

Sublingual Allergy Immunotherapy Market - Report Scope:

Sublingual allergy immunotherapy (SLIT) is a treatment method for allergic conditions, such as allergic rhinitis, asthma, and pollen allergies. SLIT involves the administration of allergen extracts under the tongue to stimulate the immune system and build tolerance over time, reducing allergic symptoms. The market caters to hospitals, allergy clinics, and homecare settings, offering a range of sublingual tablets and drops. Market growth is driven by increasing prevalence of allergies, preference for non-invasive treatments, and advancements in allergen formulation technologies, improving patient compliance and therapeutic outcomes.

Market Growth Drivers:

The global sublingual allergy immunotherapy market is propelled by several key factors, including growing awareness about allergy management, patient preference for needle-free therapies, and rising prevalence of allergic diseases worldwide. The availability of FDA- and EMA-approved SLIT tablets for common allergens, such as grass and ragweed pollen, fosters confidence in treatment efficacy. Technological advancements in allergen extraction and standardized dosing improve safety and reduce adverse effects, further supporting market adoption. Additionally, expansion of home-based treatment options and telehealth allergy services enhances patient accessibility and adherence.

Market Restraints:

Despite promising growth prospects, the SLIT market faces challenges related to regulatory approvals, high treatment costs, and limited awareness among healthcare providers in certain regions. Variability in national and regional reimbursement policies may hinder patient access, particularly in developing economies. Furthermore, the requirement for long-term therapy (often 3-5 years) and patient adherence issues can impact treatment outcomes. Addressing these barriers requires stakeholder collaboration, educational campaigns, and cost-effective treatment strategies.

Market Opportunities:

The sublingual allergy immunotherapy market presents significant growth opportunities driven by emerging allergen formulations, personalized therapy approaches, and expanding healthcare infrastructure. Increasing research into multi-allergen SLIT tablets and novel delivery methods, such as orally disintegrating films, can improve patient convenience and adherence. Growth in pediatric and adult allergy patient populations, combined with rising awareness programs and digital health integration, creates avenues for market expansion. Strategic partnerships between pharmaceutical companies, allergy specialists, and healthcare providers can further capitalize on these opportunities.

Key Questions Answered in the Report:

What are the primary factors driving the growth of the sublingual allergy immunotherapy market globally?
Which allergen types and formulations are driving SLIT adoption across different patient demographics?
How are technological advancements in allergen standardization and delivery reshaping the competitive landscape?
Who are the key players contributing to the SLIT market, and what strategies are they employing to maintain market relevance?
What are the emerging trends and future prospects in the global sublingual allergy immunotherapy market?

Competitive Intelligence and Business Strategy

Leading players in the global sublingual allergy immunotherapy market, including ALK-Abello A/S, Stallergenes Greer, and DBV Technologies, focus on innovation, product differentiation, and strategic partnerships to gain a competitive edge. These companies invest in R&D to develop advanced sublingual tablets, drops, and multi-allergen formulations, catering to diverse patient needs and clinical requirements. Collaborations with healthcare providers, allergy specialists, and regulatory agencies facilitate market access and promote technology adoption. Moreover, emphasis on clinical trials, evidence-based practice, and patient education fosters market growth and enhances patient outcomes in the rapidly evolving allergy therapeutics landscape.

Key Companies Profiled:

ALK-Abello A/S
Stallergenes Greer
DBV Technologies
Leti Pharma
Lofarma S.p.A.
Allergy Therapeutics plc
Torii Pharmaceutical Co., Ltd.
Artu Biologicals
Allergopharma GmbH & Co. KG
Laboratorios LETI S.L.

Sublingual Allergy Immunotherapy Market Research Segmentation:

By Allergen Type:

Pollen Allergens
Dust Mite Allergens
Animal Dander Allergens
Mold Allergens
Multi-Allergen Formulations

By Product Type:

Sublingual Tablets
Sublingual Drops

By End-User:

Hospitals
Allergy Clinics
Homecare Settings

By Region:

North America
Europe
Asia Pacific
Latin America

Product Code: PMRREP14968

1. Executive Summary

1.1. Global Sublingual Allergy Immunotherapy Market Snapshot 2025 and 2032
1.2. Market Opportunity Assessment, 2025-2032, US$ Mn
1.3. Key Market Trends
1.4. Industry Developments and Key Market Events
1.5. Demand Side and Supply Side Analysis
1.6. PMR Analysis and Recommendations

2. Market Overview

2.1. Market Scope and Definitions
2.2. Value Chain Analysis
2.3. Macro-Economic Factors
- 2.3.1. Global GDP Outlook
- 2.3.2. Global GDP Outlook
- 2.3.3. Global economic Growth Forecast
- 2.3.4. Global Urbanization Growth
- 2.3.5. Other Macro-economic Factors
2.4. Forecast Factors - Relevance and Impact
2.5. COVID-19 Impact Assessment
2.6. PESTLE Analysis
2.7. Porter's Five Forces Analysis
2.8. Geopolitical Tensions: Market Impact
2.9. Regulatory and Technology Landscape

3. Market Dynamics

3.1. Drivers
3.2. Restraints
3.3. Opportunities
3.4. Trends

4. Price Trend Analysis, 2019 - 2032

4.1. Region-wise Price Analysis
4.2. Price by Segments
4.3. Price Impact Factors

5. Global Sublingual Allergy Immunotherapy Market Outlook: Historical (2019-2024) and Forecast (2025-2032)

5.1. Key Highlights
5.2. Global Sublingual Allergy Immunotherapy Market Outlook: Drug
- 5.2.1. Introduction/Key Findings
- 5.2.2. Historical Market Size (US$ Mn) Analysis by Drug, 2019-2024
- 5.2.3. Current Market Size (US$ Mn) Forecast, by Drug, 2025-2032
  - 5.2.3.1. Odactra
  - 5.2.3.2. Grastek
  - 5.2.3.3. Ragwitek
  - 5.2.3.4. Oralair
  - 5.2.3.5. Actair
- 5.2.4. Market Attractiveness Analysis: Drug
5.3. Global Sublingual Allergy Immunotherapy Market Outlook: Indication
- 5.3.1. Introduction/Key Findings
- 5.3.2. Historical Market Size (US$ Mn) Analysis by Indication, 2019-2024
- 5.3.3. Current Market Size (US$ Mn) Forecast, by Indication, 2025-2032
  - 5.3.3.1. Allergic Rhinitis
  - 5.3.3.2. Allergic Asthma
  - 5.3.3.3. Food Allergy
  - 5.3.3.4. Atopic Dermatitis
  - 5.3.3.5. Others
- 5.3.4. Market Attractiveness Analysis: Indication
5.4. Global Sublingual Allergy Immunotherapy Market Outlook: Allergen
- 5.4.1. Introduction/Key Findings
- 5.4.2. Historical Market Size (US$ Mn) Analysis by Allergen, 2019-2024
- 5.4.3. Current Market Size (US$ Mn) Forecast, by Allergen, 2025-2032
  - 5.4.3.1. Pollen
  - 5.4.3.2. House Dust Mites
  - 5.4.3.3. Mold
  - 5.4.3.4. Animal Dander
  - 5.4.3.5. Bee Venom
  - 5.4.3.6. Cockroaches/Insects
  - 5.4.3.7. Others
- 5.4.4. Market Attractiveness Analysis: Allergen
5.5. Global Sublingual Allergy Immunotherapy Market Outlook: Distribution Channel
- 5.5.1. Introduction/Key Findings
- 5.5.2. Historical Market Size (US$ Mn) Analysis by Distribution Channel, 2019-2024
- 5.5.3. Current Market Size (US$ Mn) Forecast, by Distribution Channel, 2025-2032
  - 5.5.3.1. Institutional Sales
  - 5.5.3.2. Retail Sales
- 5.5.4. Market Attractiveness Analysis: Distribution Channel

6. Global Sublingual Allergy Immunotherapy Market Outlook: Region

6.1. Key Highlights
6.2. Historical Market Size (US$ Mn) Analysis by Region, 2019-2024
6.3. Current Market Size (US$ Mn) Forecast, by Region, 2025-2032
- 6.3.1. North America
- 6.3.2. Europe
- 6.3.3. East Asia
- 6.3.4. South Asia & Oceania
- 6.3.5. Latin America
- 6.3.6. Middle East & Africa
6.4. Market Attractiveness Analysis: Region

7. North America Sublingual Allergy Immunotherapy Market Outlook: Historical (2019-2024) and Forecast (2025-2032)

7.1. Key Highlights
7.2. Pricing Analysis
7.3. North America Market Size (US$ Mn) Forecast, by Country, 2025-2032
- 7.3.1. U.S.
- 7.3.2. Canada
7.4. North America Market Size (US$ Mn) Forecast, by Drug, 2025-2032
- 7.4.1. Odactra
- 7.4.2. Grastek
- 7.4.3. Ragwitek
- 7.4.4. Oralair
- 7.4.5. Actair
7.5. North America Market Size (US$ Mn) Forecast, by Indication, 2025-2032
- 7.5.1. Allergic Rhinitis
- 7.5.2. Allergic Asthma
- 7.5.3. Food Allergy
- 7.5.4. Atopic Dermatitis
- 7.5.5. Others
7.6. North America Market Size (US$ Mn) Forecast, by Allergen, 2025-2032
- 7.6.1. Pollen
- 7.6.2. House Dust Mites
- 7.6.3. Mold
- 7.6.4. Animal Dander
- 7.6.5. Bee Venom
- 7.6.6. Cockroaches/Insects
- 7.6.7. Others
7.7. North America Market Size (US$ Mn) Forecast, by Distribution Channel, 2025-2032
- 7.7.1. Institutional Sales
- 7.7.2. Retail Sales

8. Europe Sublingual Allergy Immunotherapy Market Outlook: Historical (2019-2024) and Forecast (2025-2032)

8.1. Key Highlights
8.2. Pricing Analysis
8.3. Europe Market Size (US$ Mn) Forecast, by Country, 2025-2032
- 8.3.1. Germany
- 8.3.2. Italy
- 8.3.3. France
- 8.3.4. U.K.
- 8.3.5. Spain
- 8.3.6. Russia
- 8.3.7. Rest of Europe
8.4. Europe Market Size (US$ Mn) Forecast, by Drug, 2025-2032
- 8.4.1. Odactra
- 8.4.2. Grastek
- 8.4.3. Ragwitek
- 8.4.4. Oralair
- 8.4.5. Actair
8.5. Europe Market Size (US$ Mn) Forecast, by Indication, 2025-2032
- 8.5.1. Allergic Rhinitis
- 8.5.2. Allergic Asthma
- 8.5.3. Food Allergy
- 8.5.4. Atopic Dermatitis
- 8.5.5. Others
8.6. Europe Market Size (US$ Mn) Forecast, by Allergen, 2025-2032
- 8.6.1. Pollen
- 8.6.2. House Dust Mites
- 8.6.3. Mold
- 8.6.4. Animal Dander
- 8.6.5. Bee Venom
- 8.6.6. Cockroaches/Insects
- 8.6.7. Others
8.7. Europe Market Size (US$ Mn) Forecast, by Distribution Channel, 2025-2032
- 8.7.1. Institutional Sales
- 8.7.2. Retail Sales

9. East Asia Sublingual Allergy Immunotherapy Market Outlook: Historical (2019-2024) and Forecast (2025-2032)

9.1. Key Highlights
9.2. Pricing Analysis
9.3. East Asia Market Size (US$ Mn) Forecast, by Country, 2025-2032
- 9.3.1. China
- 9.3.2. Japan
- 9.3.3. South Korea
9.4. East Asia Market Size (US$ Mn) Forecast, by Drug, 2025-2032
- 9.4.1. Odactra
- 9.4.2. Grastek
- 9.4.3. Ragwitek
- 9.4.4. Oralair
- 9.4.5. Actair
9.5. East Asia Market Size (US$ Mn) Forecast, by Indication, 2025-2032
- 9.5.1. Allergic Rhinitis
- 9.5.2. Allergic Asthma
- 9.5.3. Food Allergy
- 9.5.4. Atopic Dermatitis
- 9.5.5. Others
9.6. East Asia Market Size (US$ Mn) Forecast, by Allergen, 2025-2032
- 9.6.1. Pollen
- 9.6.2. House Dust Mites
- 9.6.3. Mold
- 9.6.4. Animal Dander
- 9.6.5. Bee Venom
- 9.6.6. Cockroaches/Insects
- 9.6.7. Others
9.7. East Asia Market Size (US$ Mn) Forecast, by Distribution Channel, 2025-2032
- 9.7.1. Institutional Sales
- 9.7.2. Retail Sales

10. South Asia & Oceania Sublingual Allergy Immunotherapy Market Outlook: Historical (2019-2024) and Forecast (2025-2032)

10.1. Key Highlights
10.2. Pricing Analysis
10.3. South Asia & Oceania Market Size (US$ Mn) Forecast, by Country, 2025-2032
- 10.3.1. India
- 10.3.2. Southeast Asia
- 10.3.3. ANZ
- 10.3.4. Rest of SAO
10.4. South Asia & Oceania Market Size (US$ Mn) Forecast, by Drug, 2025-2032
- 10.4.1. Odactra
- 10.4.2. Grastek
- 10.4.3. Ragwitek
- 10.4.4. Oralair
- 10.4.5. Actair
10.5. South Asia & Oceania Market Size (US$ Mn) Forecast, by Indication, 2025-2032
- 10.5.1. Allergic Rhinitis
- 10.5.2. Allergic Asthma
- 10.5.3. Food Allergy
- 10.5.4. Atopic Dermatitis
- 10.5.5. Others
10.6. South Asia & Oceania Market Size (US$ Mn) Forecast, by Allergen, 2025-2032
- 10.6.1. Pollen
- 10.6.2. House Dust Mites
- 10.6.3. Mold
- 10.6.4. Animal Dander
- 10.6.5. Bee Venom
- 10.6.6. Cockroaches/Insects
- 10.6.7. Others
10.7. South Asia & Oceania Market Size (US$ Mn) Forecast, by Distribution Channel, 2025-2032
- 10.7.1. Institutional Sales
- 10.7.2. Retail Sales

11. Latin America Sublingual Allergy Immunotherapy Market Outlook: Historical (2019-2024) and Forecast (2025-2032)

11.1. Key Highlights
11.2. Pricing Analysis
11.3. Latin America Market Size (US$ Mn) Forecast, by Country, 2025-2032
- 11.3.1. Brazil
- 11.3.2. Mexico
- 11.3.3. Rest of LATAM
11.4. Latin America Market Size (US$ Mn) Forecast, by Drug, 2025-2032
- 11.4.1. Odactra
- 11.4.2. Grastek
- 11.4.3. Ragwitek
- 11.4.4. Oralair
- 11.4.5. Actair
11.5. Latin America Market Size (US$ Mn) Forecast, by Indication, 2025-2032
- 11.5.1. Allergic Rhinitis
- 11.5.2. Allergic Asthma
- 11.5.3. Food Allergy
- 11.5.4. Atopic Dermatitis
- 11.5.5. Others
11.6. Latin America Market Size (US$ Mn) Forecast, by Allergen, 2025-2032
- 11.6.1. Pollen
- 11.6.2. House Dust Mites
- 11.6.3. Mold
- 11.6.4. Animal Dander
- 11.6.5. Bee Venom
- 11.6.6. Cockroaches/Insects
- 11.6.7. Others
11.7. Latin America Market Size (US$ Mn) Forecast, by Distribution Channel, 2025-2032
- 11.7.1. Institutional Sales
- 11.7.2. Retail Sales

12. Middle East & Africa Sublingual Allergy Immunotherapy Market Outlook: Historical (2019-2024) and Forecast (2025-2032)

12.1. Key Highlights
12.2. Pricing Analysis
12.3. Middle East & Africa Market Size (US$ Mn) Forecast, by Country, 2025-2032
- 12.3.1. GCC Countries
- 12.3.2. South Africa
- 12.3.3. Northern Africa
- 12.3.4. Rest of MEA
12.4. Middle East & Africa Market Size (US$ Mn) Forecast, by Drug, 2025-2032
- 12.4.1. Odactra
- 12.4.2. Grastek
- 12.4.3. Ragwitek
- 12.4.4. Oralair
- 12.4.5. Actair
12.5. Middle East & Africa Market Size (US$ Mn) Forecast, by Indication, 2025-2032
- 12.5.1. Allergic Rhinitis
- 12.5.2. Allergic Asthma
- 12.5.3. Food Allergy
- 12.5.4. Atopic Dermatitis
- 12.5.5. Others
12.6. Middle East & Africa Market Size (US$ Mn) Forecast, by Allergen, 2025-2032
- 12.6.1. Pollen
- 12.6.2. House Dust Mites
- 12.6.3. Mold
- 12.6.4. Animal Dander
- 12.6.5. Bee Venom
- 12.6.6. Cockroaches/Insects
- 12.6.7. Others
12.7. Middle East & Africa Market Size (US$ Mn) Forecast, by Distribution Channel, 2025-2032
- 12.7.1. Institutional Sales
- 12.7.2. Retail Sales

13. Competition Landscape

13.1. Market Share Analysis, 2024
13.2. Market Structure
- 13.2.1. Competition Intensity Mapping
- 13.2.2. Competition Dashboard
13.3. Company Profiles
- 13.3.1. ALK Abello
  - 13.3.1.1. Company Overview
  - 13.3.1.2. Product Portfolio/Offerings
  - 13.3.1.3. Key Financials
  - 13.3.1.4. SWOT Analysis
  - 13.3.1.5. Company Strategy and Key Developments
- 13.3.2. Stallergenes Greer
- 13.3.3. Allergy Therapeutics
- 13.3.4. Aimmune Therapeutics
- 13.3.5. Merck
- 13.3.6. Biomay AG
- 13.3.7. HAL Allergy Group
- 13.3.8. DBV Technologies
- 13.3.9. Merck KgaA
- 13.3.10. WOLWpharma

14. Appendix

14.1. Research Methodology
14.2. Research Assumptions
14.3. Acronyms and Abbreviations